Trimetazidine affects MCU expression to restore ischemic heart function via ROS/NFκB pathway inhibition : Journal of Cardiovascular Pharmacology

Journal Logo

Original Article: CARDIAC

Trimetazidine affects MCU expression to restore ischemic heart function via ROS/NFκB pathway inhibition

Xiao, Zilong M.M1,2,4,5,*; Guan, Lichun Ph.D, M.D6,*; Shi, Hui Ph.D1,2,4,5; Yu, Yong M.M2,3; Yu, Ziqing Ph.D1,2,4,5; Qin, Shengmei M.D1,2,4,5; Su, Yangang Ph.D, M.D1,2,4,5,#; Chen, Ruizhen Ph.D, M.D1,2,3,4,5,#; Ge, Junbo Ph.D, M.D1,2,3,4,5; Li, Minghui Ph.D, M.D1,2,4,5,#

Author Information
Journal of Cardiovascular Pharmacology ():10.1097/FJC.0000000000001434, May 10, 2023. | DOI: 10.1097/FJC.0000000000001434
  • Open
  • PAP

Abstract

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.